White Papers

  1. US Healthcare System Overview 4/29/2026

    A clear guide to U.S. coverage, regulation, and reimbursement: who decides care, how products gain access, and how policy and financing shape cost, value, and patient access.

  2. Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere 4/27/2026

    Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.

  3. Why Life Science Organizations Need A Chief Patient Officer Function 4/27/2026

    Bridging the gap between innovation and impact, this exploration of the Chief Patient Officer role offers a strategic framework to integrate patient insights and de-risk the product lifecycle.

  4. The Next Era Of eCOA Is AI 4/15/2026

    Discover how AI is moving beyond the hype to streamline clinical study builds. Explore practical ways to automate protocol digitization and UAT scripts while preparing for future patient tools.

  5. Pharma R&D Annual Review Supplement: New Active Substances 4/15/2026

    Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.

  6. Futureproofing Post-Approval Compliance 4/15/2026

    In the post-approval stage, a synergistic operating model brings PV and regulatory functions under one umbrella: a single governance structure with shared decision cycles, templates, and evidence.

  7. What Re-Acquisition In Retinal Imaging Is Really Costing Your Program 4/6/2026

    High screen failure rates and patient dropout often stem from preventable imaging errors. Learn how proactive quality control and patient-centric logistics secure critical retinal trial data.

  8. A New Era Of ADC Development Demands A New Kind Of Partner 3/30/2026

    Explore how to navigate the evolution of antibody-drug conjugates by mastering AI-driven selection, dose optimization, and new regulatory strategies for earlier-line clinical success.

  9. Innovating With Generative And Agentic Artificial Intelligence 3/30/2026

    Discover how specialized AI is revolutionizing clinical trials by enhancing data quality and operational speed through curated training, human oversight, and objective scientific analysis.

  10. Combination Therapy Dose Optimization In Oncology Trials 3/30/2026

    Optimize dose selection in oncology trials by moving beyond toxicity limits. Use advanced modeling and benefit-risk analysis to improve efficacy and meet modern regulatory standards.